SynZeal Research PVT LTD
All Categories
  • All Categories
  • Accessories
  • Accessories & More
  • Butters & Eggs
  • Camera & Video
  • Mornitors
  • Tablets
  • Laptops
  • Handbags
  • Headphone & Speaker
  • Herbs & botanicals
  • Vegetables
  • Shop
  • Laptops & Desktops
  • Watchs
  • Electronic
standards@synzeal.com

Blog

Blog archive

2020

May (1)

June (1)

August (2)

September (1)

October (7)

November (3)

2021

January (9)

February (2)

March (7)

April (1)

May (1)

June (4)

July (2)

August (2)

September (3)

December (2)

2022

January (4)

February (3)

March (5)

April (5)

May (1)

2023

July (2)

Amoxicillin

Date Wednesday, October 21, 2020 /

Amoxicillin belongs to the class of organiccompounds known as penicillins. Amoxicillin is an antibiotic used to treat a number of bacterialinfections. These include middle earinfection, strepthroat, pneumonia, skininfections, and urinarytractinfections among others. Amoxicillin was discovered in 1958 and came into medical use in 1972. Amoxicillin is available from 2017.

Read More

Aprepitant

Date Tuesday, October 6, 2020 /

Aprepitant an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents. Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It was approved by the Food and Drug Administration (FDA) in 2003. In 2008, fosaprepitant, an intravenous form of Aprepitant was approved.

Read More

Apalutamide

Date Thursday, October 1, 2020 /

Apalutamide is a small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity. It has been used in trials studying the treatment of Prostate Cancer, Hepatic Impairment, Prostatic Neoplasms, Castration-Resistant Prostate Cancer, and Prostatic Neoplasms, Castration-Resistant, among others. Apalutamide was first described in 2007, and was approved for the treatment of prostate cancer in February 2018.

Read More

Anastrozole

Date Sunday, September 27, 2020 /

Anastrozole is a non-steroidal aromatase inhibitor used to decrease circulating estrogen levels in the treatment of postmenopausal women with estrogen-responsive breast cancer. Aromatase inhibitors, including anastrozole, have become endocrine drugs of choice in the treatment of postmenopausal breast cancer due to a more favourable efficacy and adverse effect profile as compared to earlier estrogen receptor modulators such as tamoxifen.

Read More

Sugammadex

Date Friday, August 28, 2020 /

Sugammadex is used to reverse neuromuscular blockade after administration of the amino steroid non-depolarizing neuromuscular-blocking agents such as Vecuronium or Rocuronium. It is the first selective relaxant binding agent (SRBA). Sugammadex Sodium is the sodium salt form of the biologically inert, selective relaxant binding agent (SRBA) sugammadex, a modified, anionic cyclodextrin derivative containing a hydrophilic exterior and a hydrophobic core, with neuromuscular blocking drug (NMBD) reversal activity.

Read More

DEXAMETHASONE

Date Monday, June 22, 2020 /

Dexamethasone is used to treat conditions such as arthritis, blood/hormone/immune system disorders, allergic reactions, certain skin and eye conditions, breathing problems, certain bowel disorders, and certain cancers. Recently it is being hailed as a wonder cure for Covid-19 after the study group conducting a clinical trial in United Kingdom. A drug named dexamethasone is the talk of the hour given recent claims that it can cut mortality in patients with severe forms of COVID-19 by a third. In COVID-19 patients, dexamethasone serves to dampen the body’s immune response when it becomes too aggressive to control by other means.

Read More

Pharmaceutical Reference Standards available for COVID-19 Research Projects

Date Friday, May 1, 2020 /

Hydroxychloroquine # The antimalarial drug chloroquine and its safer derivative hydroxychloroquine are commonly prescribed medication in the treatment of uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, and systemic lupus erythematosus. These drugs have also attracted attention over the past few decades as a potential antiviral agent, currently as a possible treatment for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19. Reports found that chloroquine could inhibit SARS-CoV-2 in vitro, and showed apparent efficacy in treating COVID-19 in humans. The US Food and Drug Administration has designated hydroxychloroquine for off-label, compassionate use for treating COVID-19, and WHO added the drug to its large global solidarity trial to test a variety of potential treatments.

Read More